From March 16 to 19, 2025, the MDA Clinical & Scientific Conference took place in Dallas, USA—one of the largest events dedicated to the research and treatment of neuromuscular diseases. A representative of Pharm&Access participated in the conference, reaffirming the company's strong engagement with the global scientific community and current research in rare diseases.

During the conference, experts discussed the latest diagnostic and therapeutic approaches for neuromuscular disorders, including the prospects of gene and cell therapy. Participants presented research aimed at improving patients' quality of life, reviewed clinical cases, and exchanged experiences on managing rare genetic conditions.

The MDA Clinical & Scientific Conference annually brings together leading specialists—physicians, researchers, and pharmaceutical industry representatives—to explore innovative approaches in neuromuscular disease treatment. Participation in such events allows Pharm&Access to stay at the forefront of modern medical advancements, contributing to the implementation of cutting-edge technologies in clinical practice.

#rarediseasecompanykazakhstan #businessdevelopmentinkazakhstan #CentralAsia #orphandiseasepatientsinKazakhstan #orphanpharmaceuticalcompanyinKazakhstan #rarediseasepatientsinCentralAsia #orphanpharmacompany